Document is current
Any future updates will be listed below
-
Authors
Wong, Stephanie M. Y.
Suen, Y. N.
Wong, Charlotte W. C.
Chan, Sherry K. W.
Hui, Christy L. M.
Chang, W. C.
Lee, Edwin H. M.
Cheng, Calvin P. W.
Ho, Garrett C. L.
Lo, Gladys Goh
Leung, Eric Y. L.
Yeung, Paul K. M. Au
Chen, Sirong
Honer, William G.
Mak, Henry K. F.
Sham, P. C.
McKenna, Peter J.
Pomarol-Clotet, Edith
Veronese, Mattia
Howes, Oliver D.
Chen, Eric Y. H.
-
Funding
Funding for this research was provided by:
Health and Medical Research Fund
- License Information
-
More Information
Article History
Received: 29 November 2021
Accepted: 10 February 2022
First Online: 25 February 2022
Declarations
:
: EYHC has received speaker honoraria from Otsuka and DSK BioPharma, research funding from Otsuka, participated in paid advisory boards for Janssen and DSK BioPharma, and received funding to attend conferences from Otsuka and DSK BioPharma. WGH has been a consultant to AbbVie and Translational Life Sciences in the past year. ODH is a part-time employee of H Lundbeck A/s. He has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche, and Viatris/Mylan. Neither does ODH or his family have holdings or financial stake in any pharmaceutical company. ODH has a patent for the use of dopaminergic imaging. Other authors declare no competing interests.
